Clearmind Medicine Inc. Common Shares (CMND) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.15
• Market Cap: $1.74M
• EPS: $-30.35
• 52-Week High: $52.40
• 52-Week Low: $1.05

Market Sentiment

Clearmind Medicine Inc. Common Shares currently has a Bullish sentiment score of 0.47.

About Clearmind Medicine Inc. Common Shares

Clearmind Medicine Inc. (CMND) is an innovative preclinical pharmaceutical company based in Vancouver, Canada, specializing in the development of groundbreaking psychedelic therapies to address significant unmet medical needs in mental health. By focusing on neglected health challenges, Clearmind aims to pioneer research into psychedelic compounds that could enhance existing treatment models. The company's comprehensive pipeline underscores its dedication to advancing novel therapeutic soluti...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Clearmind Medicine Inc. Common Shares and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CMND pay dividends?

Clearmind Medicine Inc. Common Shares (CMND) does not currently pay a regular dividend.

What is CMND's market cap?

Clearmind Medicine Inc. Common Shares (CMND) has a market capitalization of $1.74M with a current stock price of $1.15.